Re-vana

Re–Vana Therapeutics Ltd

Re-Vana Therapeutics develops sustained-release biodegradable implants for delivering drugs to the eye to treat patients with vision-threatening diseases such as macular degeneration.

oculex-pharmaceuticals

This company develops biodegradable intraocular implants and drug delivery systems to treat retinal diseases for patients with conditions such as macular oedema.

Eyexora

This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.

Biophta

This company develops self-administered ocular inserts providing seven-day continuous drug release for patients with glaucoma and macular oedema.

Pykus

This company develops a biodegradable hydrogel retinal sealant to assist recovery for patients undergoing vitrectomy surgery.

VisusNano

This company develops drug-eluting intraocular lens implants for patients undergoing cataract surgery to eliminate the need for post-operative eye drops.

INEYE Therapeutics

This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.

Oxular

Oxular develops drug delivery devices and sustained-release therapeutics for treating retinal diseases in patients with vision disorders.